Literature DB >> 2044223

Anti-M4 antibodies in primary biliary cirrhosis react with sulphite oxidase, an enzyme of the mitochondrial inter-membrane space.

R Klein1, P A Berg.   

Abstract

Testing three anti-M2/anti-M4-positive and three anti-M2 positive/anti-M4-negative primary biliary cirrhosis (PBC) marker sera against different mitochondrial enzymes by ELISA it could be shown that only the anti-M4-positive sera reacted with pyruvate dehydrogenase (M2) and sulphite oxidase (SO), an enzyme of the mitochondrial inter-membrane space in parallel. Absorption of these sera with SO abolished completely the anti-M4 antibodies but had no effect on the anti-M2 activity. The specificity of this reaction was also documented by examining 30 anti-M2/anti-M4-positive sera showing that 28 of them were positive with SO. Among ten anti-M2/anti-M8-positive but anti-M4-negative PBC sera, four became positive when tested against SO, indicating a higher sensitivity of SO for the demonstration of anti-M4. Retesting sera from 76 PBC patients with defined anti-mitochondrial antibody (AMA) profiles who had been followed for up to 18 years against SO by ELISA and complement fixation test (CFT), none of 32 patients with profile A B (positive for anti-M2 and/or anti-M9 by ELISA; benign course) but 33 of 44 patients with profile C/D (anti-M2/anti-M4 and or anti-M8 positive by CFT and or ELISA; progressive course) were positive. These data indicate that sulphite oxidase can be used in the ELISA for the detection of anti-M4 antibodies which may be of prognostic relevance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044223      PMCID: PMC1535421     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

Review 1.  Heterogeneity of antimitochondrial antibodies.

Authors:  P A Berg; R Klein
Journal:  Semin Liver Dis       Date:  1989-05       Impact factor: 6.115

2.  Anti-M9 antibodies in sera from patients with primary biliary cirrhosis recognize an epitope of glycogen phosphorylase.

Authors:  R Klein; P A Berg
Journal:  Clin Exp Immunol       Date:  1990-07       Impact factor: 4.330

3.  Characterization of a new mitochondrial antigen-antibody system (M9/anti-M9) in patients with anti-M2 positive and anti-M2 negative primary biliary cirrhosis.

Authors:  R Klein; P A Berg
Journal:  Clin Exp Immunol       Date:  1988-10       Impact factor: 4.330

4.  Characterization and clinical relevance of a new complement-fixing antibody--anti-M8--in patients with primary biliary cirrhosis.

Authors:  P Weber; J Brenner; E Stechemesser; R Klein; U Weckenmann; G Klöppel; M Kirchhof; V Fintelmann; P A Berg
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

Review 5.  Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology.

Authors:  M E Gershwin; R L Coppel; I R Mackay
Journal:  Hepatology       Date:  1988 Jan-Feb       Impact factor: 17.425

6.  Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies.

Authors:  P A Berg; K H Wiedmann; T Sayers; G Klöppel; H Lindner
Journal:  Lancet       Date:  1980 Dec 20-27       Impact factor: 79.321

7.  Demonstration of "naturally occurring mitochondrial antibodies" in family members of patients with primary biliary cirrhosis.

Authors:  R Klein; P A Berg
Journal:  Hepatology       Date:  1990-08       Impact factor: 17.425

8.  Transport of the precursor for sulfite oxidase into intermembrane space of liver mitochondria: binding of the precursor to outer mitochondrial membrane.

Authors:  H Ono; A Ito
Journal:  J Biochem       Date:  1984-02       Impact factor: 3.387

9.  Mitochondrial antibodies in chronic liver diseases and connective tissue disorders: further characterization of the autoantigens.

Authors:  F Meek; E L Khoury; D Doniach; H Baum
Journal:  Clin Exp Immunol       Date:  1980-07       Impact factor: 4.330

10.  Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens.

Authors:  S J Yeaman; S P Fussey; D J Danner; O F James; D J Mutimer; M F Bassendine
Journal:  Lancet       Date:  1988-05-14       Impact factor: 79.321

View more
  10 in total

Review 1.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

Review 2.  Autoantigens in primary biliary cirrhosis.

Authors:  D E Jones
Journal:  J Clin Pathol       Date:  2000-11       Impact factor: 3.411

Review 3.  The role of mitochondria in rheumatic diseases.

Authors:  Yann L C Becker; Bhargavi Duvvuri; Paul R Fortin; Christian Lood; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2022-09-29       Impact factor: 32.286

4.  Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance.

Authors:  B Preuss; C Berg; F Altenberend; M Gregor; S Stevanovic; R Klein
Journal:  Clin Exp Immunol       Date:  2007-08-17       Impact factor: 4.330

5.  Immunoblotting as a confirmatory test for antimitochondrial antibodies in primary biliary cirrhosis.

Authors:  G Provenzano; O Diquattro; A Craxì; P Almasio; G Pinzello; L Marino; G Fiorentino; F Rinaldi; L Pagliaro
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

6.  IgG from patients with liver diseases inhibit mitochondrial respiration in permeabilized oxidative muscle cells: impaired function of intracellular energetic units?

Authors:  Lumme Kadaja; Kai E Kisand; Nadezhda Peet; Urmo Braun; Kaja Metsküla; Kaupo Teesalu; Riina Vibo; Kalle V Kisand; Raivo Uibo; Harald Jockusch; Enn K Seppet
Journal:  Mol Cell Biochem       Date:  2004 Jan-Feb       Impact factor: 3.396

7.  Anti-M4 antibodies measured by a sulphite oxidase ELISA in patients with both anti-centromere and anti-M2 antibodies.

Authors:  C C Bunn; M McMorrow
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

8.  Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA.

Authors:  Yann Becker; Geneviève Marcoux; Isabelle Allaeys; Anne-Sophie Julien; Renée-Claude Loignon; Hadrien Benk-Fortin; Emmanuelle Rollet-Labelle; Joyce Rauch; Paul R Fortin; Eric Boilard
Journal:  Front Immunol       Date:  2019-05-10       Impact factor: 7.561

9.  Anti-mitochondrial Antibodies in Patients with Dilated Cardiomyopathy.

Authors:  Tetsuro Yokokawa; Akiomi Yoshihisa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Yasuchika Takeishi
Journal:  Intern Med       Date:  2021-01-15       Impact factor: 1.271

10.  Sulphite oxidase (SO) - a mitochondrial autoantigen as target for humoral and cellular immune reactions in primary sclerosing cholangitis.

Authors:  Beate E Preuß; Christoph P Berg; Christoph Werner; Sandra Plankenhorn; Nisar P Malek; Reinhild Klein
Journal:  BMC Gastroenterol       Date:  2018-05-02       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.